| 3 months N = 75 | 6 months N = 69 | ||
---|---|---|---|---|
β (95% CI) | P value | β (95% CI) | P value | |
Female sex | − 18.00 (− 26.58, − 10.33) | 0.002 | − 20.21 (− 23.04, − 10.13) | < 0.001 |
Age | − 0.46 (− 0.53, − 0.37) | < 0.001 | − 0.270 (− 0.37, − 0.26) | < 0.001 |
Any pre-existing comorbidities | − 15.28 (− 23.85, − 7.30) | 0.003 | − 11.36 (− 17.81, − 1.39) | 0.07 |
Incubation period (n = 50) | 0.69 (− 1.137, 1.41) | 0.19 | 0.17 (− 0.01, 0.42) | 0.31 |
Period of onset (n = 55) | 0.06 (− 0.13, 0.10) | 0.32 | 0.06 (− 0.22, 0.08) | 0.11 |
Time from 1st symptom to admission | 1.19 (− 1.64, 2.10) | 0.19 | 0.70 (− 1.17, 1.25) | 0.13 |
Difficulty breathing on admission | − 9.61 (− 14.91, 8.08) | 0.18 | − 3.00 (− 16.57, 0.08) | 0.35 |
Clinical Features during first 24 h of admission | ||||
Highest systolic blood pressure (mmHg)* | − 0.21 (− 0.48, − 0.15) | 0.07 | − 0.21 (− 0.27, 0.02) | 0.01 |
Highest heart rate (bpm) | − 0.08 (− 0.38, 0.20) | 0.64 | − 0.08 (− 0.40, -0.01) | 0.18 |
Heart rate range (bpm)* | − 0.07 (− 0.42, 0.30) | 0.70 | − 0.13 (− 0.31, 0.01) | 0.19 |
Highest temperature (°C) | 5.07 (− 7.16, 8.76) | 0.16 | 1.97 (− 13.28, 3.17) | 0.23 |
SpO2 on admission (%)* | 0.55 (0.40, 3.81) | 0.21 | 0.72 (0.00, 3.26) | 0.03 |
SOFA** score1* 0 > = 1 | − 6.17 (− 17.98, − 0.01) | 0.27 | − 3.97 (− 17.98, − 0.85) | 0.82 |
Urine output (ml/h) | 0.04 (− 0.14, 0.04) | 0.20 | 0.01 (− 0.02, 0.03) | 0.34 |
Creatinine (μmol/L) | 0.16 (− 0.06, 0.27) | 0.23 | 0.01 (− 0.07, 0.17) | 0.93 |
Platelets (× 109/L) | − 0.06 (− 0.10, − 0.04) | 0.01 | − 0.03 (− 0.08, 0.00) | 0.13 |